FLEX ORTHOPAEDICS, INC.

Medtech · Private

Orthopaedic implants for ankle-hindfoot reconstruction that preserve joint mobility as an alternative to fusion or amputation

Grants
$882K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A Compliant Intramedullary Stem to Increase Longevity of Total Knee Replacements$274,997
Federal grantDepartment of Health and Human Services · Phase I · A Compliant Ankle Endoprosthesis To Treat Ankle-hindfoot Pathology$299,996
Federal grantDepartment of Health and Human Services · Phase I · A Compliant Intramedullary Stem to Increase Longevity of Revision Total Knee Arthroplasty$306,871
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2030MAGNIFY BIOSCIENCES INC.——
2031Cumulus——
2032QSCINT IMAGING SOLUTIONS, LLC——
2033FLEX ORTHOPAEDICS, INC.——
2034SONOVANCE, INC.——
2035ENDOTAT BIOTECHNOLOGIES LLC——
2036EMBIOSYS INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.